vorinostat has been researched along with Alveolitis, Fibrosing in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Excerpt | Relevance | Reference |
---|---|---|
"Idiopathic pulmonary fibrosis (IPF) is a deadly disease characterized by chronic inflammation and excessive collagen accumulation in the lung." | 1.39 | Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts. ( Hock, T; Liu, H; Sanders, YY; Thannickal, VJ; Zhang, X, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, X | 1 |
Liu, H | 1 |
Hock, T | 1 |
Thannickal, VJ | 1 |
Sanders, YY | 1 |
1 other study available for vorinostat and Alveolitis, Fibrosing
Article | Year |
---|---|
Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts.
Topics: Animals; Cells, Cultured; Chromatin; Collagen Type III; Down-Regulation; Fibroblasts; Histone Deacet | 2013 |